Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer. | Int J Environ Res Public Health | 2022 | 36360779 | PubTator, text mining | PubMed |
| Genetic Hearing Loss Affects Cochlear Processing. | Genes (Basel) | 2022 | 36360160 | PubTator, text mining | PubMed |
| Bioengineering Human Pluripotent Stem Cell-Derived Retinal Organoids and Optic Vesicle-Containing Brain Organoids for Ocular Diseases. | Cells | 2022 | 36359825 | PubTator, text mining | PubMed |
| Five years' experience of the clinical exome sequencing in a Spanish single center. | Sci Rep | 2022 | 36357507 | PubTator, text mining | PubMed |
| Carrier frequency and incidence estimation of RPE65-associated inherited retinal diseases in East Asian population by population database-based analysis. | Orphanet J Rare Dis | 2022 | 36352427 | PubTator, text mining | PubMed |
Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance. | Front Immunol | 2022 | 36341392 | PubTator, text mining | PubMed |
| Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial. | Front Neurosci | 2022 | 36340792 | PubTator, text mining | PubMed |
| Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma. | Front Genet | 2022 | 36338990 | PubTator, text mining | PubMed |
| The nucleoplasmic phase of pre-40S formation prior to nuclear export. | Nucleic Acids Res | 2022 | 36321656 | PubTator, text mining | PubMed |
| Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities. | Asian J Pharm Sci | 2022 | 36320315 | PubTator, text mining | PubMed |
| Genome-wide detection of human variants that disrupt intronic branchpoints. | Proc Natl Acad Sci U S A | 2022 | 36306325 | PubTator, text mining | PubMed |
| Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy. | J Transl Med | 2022 | 36303162 | PubTator, text mining | PubMed |
| Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma. | Front Genet | 2022 | 36299585 | PubTator, text mining | PubMed |
| Pseudorabies Virus Associations in Wild Animals: Review of Potential Reservoirs for Cross-Host Transmission. | Viruses | 2022 | 36298809 | PubTator, text mining | PubMed |
| The Deletion of US3 Gene of Pseudorabies Virus (PRV) ΔgE/TK Strain Induces Increased Immunogenicity in Mice. | Vaccines (Basel) | 2022 | 36298468 | PubTator, text mining | PubMed |
| Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies. | Pharmaceuticals (Basel) | 2022 | 36297367 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy. | Diagnostics (Basel) | 2022 | 36292100 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss. | Cells | 2022 | 36291196 | PubTator, text mining | PubMed |
Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping. | Mol Vis | 2022 | 36284670 | PubTator, text mining | PubMed |
| Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021. | Transpl Infect Dis | 2022 | 36271650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=28